Methods for treating prostate conditions
US8703726B2 · kind B2 · utility
6Cited by
17References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 2010 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | May 27, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating prostate cancer involving the administration of a compound that selectively inhibits pathological production of human vascular endothelial growth factor (VEGF) are described. Methods for treating benign prostatic hyperplasia involving the administration of a compound that selectively inhibits pathological production of human VEGF are also described. The compound may be administered as a single-agent therapy or in combination with one or more additional therapies to a human in need of such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.